Sanjivani Paranteral
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
May 19 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
APPROVES CONVERSION OF 1,97,394 WARRANTS INTO EQUITY SHARES
Source text: ID:nBSEbFs0X8
Further company coverage: SANJ.BO
(([email protected];))
May 19 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
APPROVES CONVERSION OF 1,97,394 WARRANTS INTO EQUITY SHARES
Source text: ID:nBSEbFs0X8
Further company coverage: SANJ.BO
(([email protected];))
April 8 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
SANJIVANI PARANTERAL LTD - HITESH RAJNIKANT KHONA RESIGNS AS CFO
SANJIVANI PARANTERAL LTD - PRITESH JAIN NAMED AS CFO
Source text for Eikon: ID:nBSE7BvW5P
Further company coverage: SANJ.BO
(([email protected];))
April 8 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
SANJIVANI PARANTERAL LTD - HITESH RAJNIKANT KHONA RESIGNS AS CFO
SANJIVANI PARANTERAL LTD - PRITESH JAIN NAMED AS CFO
Source text for Eikon: ID:nBSE7BvW5P
Further company coverage: SANJ.BO
(([email protected];))
Dec 25 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
APPROVED ISSUANCE OF CONVERTIBLE WARRANTS
ISSUANCE OF CONVERTIBLE WARRANTS WORTH UP TO 81.1 MILLION RUPEES
APPROVED ISSUANCE OF EQUITY SHARES WORTH UP TO 227.8 MILLION RUPEES
TO ISSUE WARRANTS TO PROMOTER ON PREFERENTIAL BASIS
TO ISSUE EQUITY SHARES ON PREFERENTIAL BASIS
Source text for Eikon: ID:nBSE239xQL
Further company coverage: SANJ.BO
(([email protected];;))
Dec 25 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
APPROVED ISSUANCE OF CONVERTIBLE WARRANTS
ISSUANCE OF CONVERTIBLE WARRANTS WORTH UP TO 81.1 MILLION RUPEES
APPROVED ISSUANCE OF EQUITY SHARES WORTH UP TO 227.8 MILLION RUPEES
TO ISSUE WARRANTS TO PROMOTER ON PREFERENTIAL BASIS
TO ISSUE EQUITY SHARES ON PREFERENTIAL BASIS
Source text for Eikon: ID:nBSE239xQL
Further company coverage: SANJ.BO
(([email protected];;))
Dec 19 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
TO CONSIDER PROPOSAL TO RAISE RESOURCES
Source text for Eikon: ID:nBSE11kd9s
Further company coverage: SANJ.BO
(([email protected];))
Dec 19 (Reuters) - Sanjivani Paranteral Ltd SANJ.BO:
TO CONSIDER PROPOSAL TO RAISE RESOURCES
Source text for Eikon: ID:nBSE11kd9s
Further company coverage: SANJ.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Sanjivani Paranteral do?
Sanjivani Paranteral Ltd is an international pharmaceutical company offering a diverse range of high-quality and affordable products such as oral solids, small volume parenterals, and sterile powder formulations.
Who are the competitors of Sanjivani Paranteral?
Sanjivani Paranteral major competitors are Speciality Medicines, Accretion Nutraveda, Guj. Inject (Kerala), Oxygenta Pharma, Chemkart India, Bio Medica Laborator, IndoAmerican Advance. Market Cap of Sanjivani Paranteral is ₹184 Crs. While the median market cap of its peers are ₹177 Crs.
Is Sanjivani Paranteral financially stable compared to its competitors?
Sanjivani Paranteral seems to be less financially stable compared to its competitors. Altman Z score of Sanjivani Paranteral is 4.57 and is ranked 7 out of its 8 competitors.
Does Sanjivani Paranteral pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sanjivani Paranteral latest dividend payout ratio is 7.34% and 3yr average dividend payout ratio is 7.34%
How has Sanjivani Paranteral allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Accounts Receivable
How strong is Sanjivani Paranteral balance sheet?
Balance sheet of Sanjivani Paranteral is strong. But short term working capital might become an issue for this company.
Is the profitablity of Sanjivani Paranteral improving?
The profit is oscillating. The profit of Sanjivani Paranteral is ₹6.69 Crs for TTM, ₹8.1 Crs for Mar 2025 and ₹6.17 Crs for Mar 2024.
Is the debt of Sanjivani Paranteral increasing or decreasing?
Yes, The net debt of Sanjivani Paranteral is increasing. Latest net debt of Sanjivani Paranteral is ₹12.92 Crs as of Mar-26. This is greater than Mar-25 when it was ₹3.33 Crs.
Is Sanjivani Paranteral stock expensive?
Sanjivani Paranteral is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Sanjivani Paranteral is 27.15, while 3 year average PE is 26.85. Also latest EV/EBITDA of Sanjivani Paranteral is 19.11 while 3yr average is 21.06.
Has the share price of Sanjivani Paranteral grown faster than its competition?
Sanjivani Paranteral has given better returns compared to its competitors. Sanjivani Paranteral has grown at ~31.16% over the last 3yrs while peers have grown at a median rate of 6.21%
Is the promoter bullish about Sanjivani Paranteral?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 31.26% and last quarter promoter holding is 31.2%.
Are mutual funds buying/selling Sanjivani Paranteral?
There is Insufficient data to gauge this.